With over 35 nationalities and a range of backgrounds represented in our Benevolent team, we aim to build an inclusive environment where our people can bring their authentic selves to work, be respected for who they are and the exceptional work they do. We welcome and actively encourage applications from all sections of society and are committed to offering equal employment opportunities regardless of sex, race, religion or belief, ethnic or national origin, marital, domestic or civil partnership status, sexual orientation, gender identity, parental status, disability, age, citizenship, or any other basis. We see our diversity as an asset as we tackle challenging problems that bridge the gap between drug discovery and technology.
Determination of the potential safety risks of compounds being progressed by BenevolentAI is of paramount importance. We are looking for a senior scientist with a background in toxicology to provide significant support to our growing portfolio of small molecule drug discovery programs. You will apply your deep understanding of regulatory toxicology to rapidly move projects through preclinical development. You will work across multiple programs, being responsible for the design, interpretation and reporting/communicating of toxicology and safety pharmacology studies that comply with relevant regulatory guidelines through close collaboration with relevant disciplines in BAI and CRO partners. Based at our London offices, you will be a core member of drug discovery project teams looking to progress drug candidates into clinical development.
We share a passion for being part of a mission that matters, and we are always looking for curious and collaborative people who share our values and want to be part of our journey. If that sounds like a fit for you, hit the apply button and join us.
BenevolentAI unites AI with human expertise to discover new and more effective medicines. Our unique computational R&D platform spans every step of the drug discovery process, powering an in-house pipeline of over 25 drug programmes. We advance our mission to reinvent drug discovery by harnessing the power of a diverse team, rich with different backgrounds, experiences, opinions and personalities. In our offices in London and New York and research facility in Cambridge (UK), we work in highly collaborative, multidisciplinary teams, harnessing skills across biology, chemistry, engineering, AI, machine learning, informatics, precision medicine and drug discovery.
Our team will only contact you from the domain @benevolent.ai. If you receive a suspicious contact request, please email email@example.com. Thank you.